Symbol			MYRX

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Myriad Pharmaceuticals Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference

2009-11-23 21:52 ET - News Release

SALT LAKE CITY, Nov. 23, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals Inc. (Nasdaq:MYRX) announced today that Adrian Hobden, President and CEO, is scheduled to present an overview of the Company at the 21st Annual Piper Jaffray Health Care Conference, at 10:00 a.m. Eastern on December 1, 2009, at the New York Palace Hotel in New York City.

The presentation will be available via live audio webcast on the Company's website at www.myriadpharma.com. An archived replay will also be located on the Company's site following the event.

About Myriad Pharmaceuticals

Myriad Pharmaceuticals, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing novel small molecule drugs that address severe medical conditions, including cancer and HIV infection. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics. For more information visit www.myriadpharma.com.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.